rs118204018
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000018.4(ACADVL):c.1246G>A(p.Ala416Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A416S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000018.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACADVL | NM_000018.4 | c.1246G>A | p.Ala416Thr | missense_variant | 12/20 | ENST00000356839.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACADVL | ENST00000356839.10 | c.1246G>A | p.Ala416Thr | missense_variant | 12/20 | 1 | NM_000018.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251462Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135910
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461862Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 727236
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74280
ClinVar
Submissions by phenotype
Very long chain acyl-CoA dehydrogenase deficiency Pathogenic:7
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2001 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 22, 2018 | The ACADVL c.1246G>A (p.Ala416Thr) variant has been reported in at least four patients in a compound heterozygous state, two of whom had mild manifestation of VLCAD deficiency (Fukao et al. 2001; Takusa et al. 2002; Brown et al. 2014; Hesse et al. 2018). The p.Ala416Thr variant was absent from 100 controls and is reported at a frequency of 0.000027 in the European (non-Finnish) population of the Genome Aggregation Database. Functional studies used transient expression of the p.Ala416Thr variant and showed residual acyl-CoA dehydrogenase activity of 10-20% of wild type (Fukao et al. 2001). Based on the evidence, the ACADVL p.Ala416Thr variant is classified as likely pathogenic for VLCAD deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, reviewed by expert panel | curation | ClinGen ACADVL Variant Curation Expert Panel, ClinGen | Aug 09, 2022 | The c.1246G>A (p.Ala416Thr) variant in ACADVL is a missense variant predicted to cause substitution of alanine by threonine at amino acid 416. This variant has been reported in several individuals affected with very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, with at least one individual showing VLCAD enzyme activity <20% of normal, which is highly specific for VLCAD deficiency (PP4_Moderate; PMID: 15210884, 20060901, 11914034, 30194637). Additionally, this variant has been reported confirmed in trans to a likely pathogenic variant and presumed in trans to several distinct variants, at least one of which is pathogenic (PM3; PMIDs: 15210884, 20060901, 11914034, 30194637). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00001591 in the total population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). Functional assays of fibroblasts transfected with this variant showed reduced ACADVL enzyme function indicating that this variant impacts protein function (PS3_Supporting; PMIDs: 11158518, 11914034). The computational predictor REVEL gives a score of 0.936, which is above the threshold of 0.75, evidence that correlates with impact to ACADVL function (PP3). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive VLCAD deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel:PP4_Moderate, PM3, PM2_Supporting, PS3_Supporting, PP3 (ACADVL VCEP specifications version 1; approved November 8, 2021). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 05, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Mar 07, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects ACADVL function (PMID: 11158518). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACADVL protein function. ClinVar contains an entry for this variant (Variation ID: 1633). This missense change has been observed in individual(s) with myopathic form of very-long chain acyl-CoA dehydrogenase deficiency (PMID: 11158518, 11914034, 15210884). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs118204018, gnomAD 0.006%). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 416 of the ACADVL protein (p.Ala416Thr). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 18, 2021 | NM_000018.3(ACADVL):c.1246G>A(A416T) is a missense variant classified as likely pathogenic in the context of very long chain acyl-CoA dehydrogenase deficiency. A416T has been observed in cases with relevant disease (PMID: 15210884, 11158518, 11914034, Mitsui_2014_(no PMID; article), 30194637). Functional assessments of this variant are available in the literature (PMID: 11158518, 20060901, 21378393). A416T has been observed in population frequency databases (gnomAD: EAS 0.01%). In summary, NM_000018.3(ACADVL):c.1246G>A(A416T) is a missense variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Nov 12, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at